Publikationer och rapporter

Vetenskapliga publikationer

Myrin-Westesson, L., Elfvinge, P., Zetterberg, E. & Olsson, A. (2025). Prevalence of heavy menstruation bleeding, iron deficiency, iron deficiency anaemia and treatment in women with von Willebrand disease – a cohort study. Research and Practice in Thrombosis and Haemostasis, 9(4), 102949. https://doi.org/10.1016/j.rpth.2025.102949

Olsson, A., Elfvinge, P., Zetterberg, E. & Myrin-Westesson, L. (2025) Prevalence and impact of heavy menstrual bleeding in women with von Willebrand disease across age groups: a retrospective study. Haemophilia, 2025; 0:1–7 https://doi.org/10.1111/hae.70127

Andersson NG, Brange H, Astermark J, Axelsson M, Baghaei F, Magnusson M, Olsson A, Olsson E, Ranta S, Westesson LM, Holmström M. Low bleeding rates after intramuscular Covid-19 vaccination in patients with haemophilia and von Willebrand disease: Outcome data from the Swedish haemophilia registry. Haemophilia. 2024 Sep;30(5):1217-1220. doi: 10.1111/hae.15063. Epub 2024 Jun 6. PMID: 38845161.

Myrin Westesson, L., Petrini, P., Engman Grahn, E. and Olsson, A. (2023) Burden on Parents of Children with Moderate or Severe Von Willebrand Disease: The Impact of Clinical Data. Haemophilia, 29.1: 390-93. https://doi.org/10.1111/hae.14718

Olsson A, Petrini P, Engman Grahn E, Myrin Westesson L. HRQoL and psychosocial aspects of burden on caregivers to children with moderate or severe von Willebrand disease. Haemophilia. 2023 Jul;29(4):1056-1062. doi: 10.1111/hae.14811. Epub 2023 Jun 8. PMID: 37291684.

Olsson A, Westesson LM, Baghaei F, Holmström M, Olsson E, Magnusson M, Ranta S, Astermark J, Andersson NG, Thanner J, Szamosi J, Daoura L, Sennfält K. Real-world prophylactic usage of recombinant factor IX Fc in Sweden: A report from the Swedish National Registry for bleeding disorders. Haemophilia. 2023 Jan;29(1):377-381. doi: 10.1111/hae.14704. Epub 2022 Dec 5. PMID: 36469854.

Holmström M, Olsson E, Astermark J, Axelsson M, Olsson A, Myrin Westesson L, Falk A, Szamosi J, Sennfält K. Real-world prophylactic usage of recombinant factor VIII Fc in Sweden: A report from the Swedish national registry for bleeding disorders. Haemophilia. 2021 Jul;27(4):e554-e558. doi: 10.1111/hae.14316. Epub 2021 May 13. PMID: 33982353.